Clinical Trials Directory

Trials / Conditions / Hepatic Arterial Infusion Chemotherapy

Hepatic Arterial Infusion Chemotherapy

8 registered clinical trials studyying Hepatic Arterial Infusion Chemotherapy — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingFOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cho
NCT07353827
Sun Yat-sen UniversityPhase 2
RecruitingHAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of
NCT06632093
First Hospital of China Medical University—
Active Not RecruitingHAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
NCT06632106
First Hospital of China Medical University—
UnknownEffect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma
NCT05416073
The Second Affiliated Hospital of Chongqing Medical UniversityPhase 4
UnknowncTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC
NCT05025592
Peking University Cancer Hospital & Institute—
RecruitingHAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
NCT06333561
Sun Yat-sen University—
CompletedHAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
NCT06631326
First Hospital of China Medical University—
CompletedHAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
NCT06184841
Peking University Cancer Hospital & InstitutePhase 1